BREAST LOBULAR CARCINOMA IN SITU
Clinical trials for BREAST LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel aims to tame breast cancer before surgery
Disease control OngoingThis early-phase trial tests an endoxifen gel applied to the breast in 32 women scheduled for mastectomy. The goal is to find the safest dose and check for skin reactions. Endoxifen may help control or lower breast cancer risk, but this study focuses on side effects and drug leve…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 12:06 UTC
-
Could a Lower-Dose pill be just as good for early breast cancer?
Disease control TerminatedThis study compares a low dose of tamoxifen with standard hormone therapies (like aromatase inhibitors) in postmenopausal women with a low-risk, hormone-positive, HER2-negative early breast cancer. The goal is to see if the low-dose option works just as well to prevent cancer fro…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC